Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,045 | -65,952 | -26,985 | -19,294 | -10,755 |
| Depreciation Amortization | 347 | 32,268 | 1,202 | 865 | 466 |
| Other Working Capital | -5,765 | 539 | -906 | -1,476 | -2,551 |
| Other Operating Activity | 1,575 | 6,688 | 5,258 | 3,821 | 1,879 |
| Operating Cash Flow | $-12,888 | $-26,457 | $-21,431 | $-16,084 | $-10,961 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,186 | -43,550 | -14,428 | -14,428 | -12,415 |
| PPE Investments | -6 | -120 | -114 | -31 | -11 |
| Sale Of Investment | 22,052 | 58,620 | 47,837 | 28,706 | 13,171 |
| Investing Cash Flow | $9,860 | $14,950 | $33,295 | $14,247 | $745 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -64 | -90 | -90 | -72 | -72 |
| Financing Cash Flow | $-64 | $-90 | $-90 | $-72 | $-72 |
| Beginning Cash Position | 24,872 | 36,469 | 36,469 | 36,469 | 36,469 |
| End Cash Position | 21,780 | 24,872 | 48,243 | 34,560 | 26,181 |
| Net Cash Flow | $-3,092 | $-11,597 | $11,774 | $-1,909 | $-10,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,888 | -26,457 | -21,431 | -16,084 | -10,961 |
| Capital Expenditure | -6 | -120 | -114 | -31 | -11 |
| Free Cash Flow | -12,894 | -26,577 | -21,545 | -16,115 | -10,972 |